Normal expiratory flow rate and lung volumes in patients with combined emphysema and interstitial lung disease: A case series and literature review

Canadian Respiratory Journal

Volumn 18, Issue 5, 2011, Pages

  Heathcote, Karen L ^a   Cockcroft, Donald W ^a   Fladeland, Derek A ^b   Fenton, Mark E ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Emphysema; Expiratory flow rates; Intersitial lung disease; Lung volumes

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DEATH; DISEASE SEVERITY; DYSPNEA; EMPHYSEMA; FATIGUE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; LUNG VOLUME; MALE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SPIROMETRY; SURVIVAL TIME;

EID: 84860469476     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/354325     Document Type: Article

References (16)

1. Cockcroft DW, Fisher KL. Near normalization of spirometry in a subject with severe emphysema complicated by amiodarone lung. Respir Med 1999;93:597-600. (Pubitemid 29476271)
2. Yernault JC, de Jonghe M, de Coster A, Englert M. Pulmonary mechanics in diffuse fibrosing alveolitis. Bull Physiopathol Respir 1975;11:231-44.
3. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:258-66 (Pubitemid 41566933)
4. Aduen JF, Zisman DA, Mobin SI, et al. Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: Implications for the diagnosis of combined obstructive and restrictive lung disease. Mayo Clin Proc 2007;82:48-54. (Pubitemid 46043228)
5. Mori H, Okubo M, Okamura M, et al. Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus. Intern Med 1992;31:189-93.
6. Brussel T, Matthay MA, Chernow B. Pulmonary manifestations of endocrine and metabolic disorders. Clin Chest Med 1989;10:645-53. (Pubitemid 20014958)
7. Forman JW, Ayers LN, Miller WC. Pulmonary diffusing capacity in chronic renal failure. Br J Dis Chest 1981;75:81-7. (Pubitemid 11212746)
8. Garcia JG, Griffith DE, Williams JS, Blevins WJ, Kronenberg RS. Reduced diffusing capacity as an isolated finding in asbestos- and silica-exposed workers. Chest 1990;98:105-11. (Pubitemid 20223674)
9. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: The value of high resolution computed tomography in assessment. Respir Med 1990;84:365-9. (Pubitemid 20287410)
10. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: A distinct underrecognised entity. Eur Respir J 2005;26:586-93. (Pubitemid 41448654)
11. Mercer BA, Wallace AM, Brinckerhoff CE, et al. Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter. Am J Respir Cell Mol Biol 2009;40:4-12.
12. Selman M. The spectrum of smoking related interstitial lung disorders: The never ending story of smoke and disease. Chest 2003;124:1185-7. (Pubitemid 37290021)
13. Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2009;15:265-71.
14. Daniil Z, Koutsokera A, Gourgoulianis K. Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds. Eur Respir J 2006;27:434. (Pubitemid 43180924)
15. Mejia M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: Decreased survival associated with severe pulmonary arterial hypertension. Chest 2009;136:10-15.
16. Brillet P, Cottin V, Letoumelin P, et al. Combined apical emphysema and basal fibrosis syndrome (emphysema/fibrosis syndrome): CT imaging features and pulmonary function tests. J Radiol 2009;90:43-51.